SITUS JUDI MBL77 OPTIONS

Cure for relapsed/refractory disorder needs to be resolved based upon prior therapy in addition to the reason why the original procedure was no longer suitable (e.g., refractoriness vs. intolerance). Ibrutinib is the current gold standard therapy for patients with relapsed/refractory disease, based on the outcome of many section I-III trials, one h